R Saperstein

942 total citations
17 papers, 703 citations indexed

About

R Saperstein is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, R Saperstein has authored 17 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in R Saperstein's work include Receptor Mechanisms and Signaling (4 papers), Pancreatic function and diabetes (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). R Saperstein is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Pancreatic function and diabetes (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). R Saperstein collaborates with scholars based in United States. R Saperstein's co-authors include Catherine A. Cullinan, Mark D. Leibowitz, Pasquale P. Vicario, Thomas W. Doebber, Philip J. Bailey, Chhabi Biswas, N. Berger, R G Smith, Nancy S. Hayes and E E Slater and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

R Saperstein

17 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Saperstein United States 9 519 210 103 90 74 17 703
H.V. Strout United States 13 512 1.0× 260 1.2× 186 1.8× 138 1.5× 102 1.4× 16 879
David J. Cowan United States 10 637 1.2× 194 0.9× 86 0.8× 19 0.2× 52 0.7× 12 831
A.V. Wallace United Kingdom 15 326 0.6× 198 0.9× 67 0.7× 19 0.2× 77 1.0× 20 706
Philip J. Rybczynski United States 17 279 0.5× 148 0.7× 83 0.8× 48 0.5× 31 0.4× 27 751
Edward J. Brady United States 11 278 0.5× 53 0.3× 147 1.4× 41 0.5× 104 1.4× 13 443
Kazimir Sestanj United States 11 273 0.5× 119 0.6× 146 1.4× 12 0.1× 40 0.5× 19 632
Janet Sredy United States 18 623 1.2× 174 0.8× 91 0.9× 52 0.6× 60 0.8× 30 1.4k
Kiyoshi Oizumi Japan 16 228 0.4× 68 0.3× 63 0.6× 35 0.4× 23 0.3× 28 588
Jaroslaw W. Żmijewski United States 10 410 0.8× 223 1.1× 38 0.4× 13 0.1× 43 0.6× 12 770
Holger Heitsch Germany 13 277 0.5× 72 0.3× 229 2.2× 19 0.2× 52 0.7× 20 756

Countries citing papers authored by R Saperstein

Since Specialization
Citations

This map shows the geographic impact of R Saperstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Saperstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Saperstein more than expected).

Fields of papers citing papers by R Saperstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Saperstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Saperstein. The network helps show where R Saperstein may publish in the future.

Co-authorship network of co-authors of R Saperstein

This figure shows the co-authorship network connecting the top 25 collaborators of R Saperstein. A scholar is included among the top collaborators of R Saperstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Saperstein. R Saperstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Saperstein, R, Sanjay Goel, & Radhashree Maitra. (2023). Noncoding RNA Profile in Reovirus Treated KRAS-Mutated Colorectal Cancer Patients. SHILAP Revista de lepidopterología. 11(4). 142–142. 2 indexed citations
2.
Hom, Gary J., M J Forrest, E.J. Brady, et al.. (2001). Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeys.. PubMed. 297(1). 299–307. 11 indexed citations
3.
Berger, N., Philip J. Bailey, Chhabi Biswas, et al.. (1996). Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.. Endocrinology. 137(10). 4189–4195. 340 indexed citations
4.
Cullinan, Catherine A., E.J. Brady, R Saperstein, & Mark D. Leibowitz. (1994). Glucose-dependent alterations of intracellular free calcium by glucagon-like peptide-1(7-36amide) in individual mouse β-cells. Cell Calcium. 15(5). 391–400. 23 indexed citations
5.
Meurer, Laura C., Richard L. Tolman, R Saperstein, et al.. (1993). ChemInform Abstract: Synthesis and Hypoglycemic Activity of Substituted 8‐(1‐Piperazinyl) imidazo(1,2‐a)pyrazines.. ChemInform. 24(20). 1 indexed citations
6.
Meurer, Laura C., Richard L. Tolman, R Saperstein, et al.. (1992). Synthesis and hypoglycemic activity of substituted 8-(1-piperazinyl)imidazo[1,2-a]pyrazines. Journal of Medicinal Chemistry. 35(21). 3845–3857. 35 indexed citations
7.
Saperstein, R, et al.. (1990). Effects of an α2-adrenoceptor antagonist on glucose tolerance in the genetically obese mouse ( ). Metabolism. 39(5). 445–451. 8 indexed citations
8.
Strout, H.V., Pasquale P. Vicario, R Saperstein, & E E Slater. (1989). The Insulin-Mimetic Effect of Vanadate Is Not Correlated with Insulin Receptor Tyrosine Kinase Activity Nor Phosphorylation in Mouse Diaphragmin Vivo. Endocrinology. 124(4). 1918–1924. 94 indexed citations
9.
Cascieri, Margaret A., et al.. (1989). Impaired insulin-like growth factor I-mediated stimulation of glucose incorporation into glycogen in vivo in the ob/ob mouse. Diabetologia. 32(6). 342–347. 8 indexed citations
10.
Saperstein, R, et al.. (1989). The effect of ponalrestat on sorbitol levels in the lens of obese and diabetic mice.. PubMed. 19(3). 553–61. 2 indexed citations
11.
Strout, H.V., Pasquale P. Vicario, R Saperstein, & E E Slater. (1988). A protein phosphotyrosine phosphatase distinct from alkaline phosphatase with activity against the insulin receptor. Biochemical and Biophysical Research Communications. 151(2). 633–640. 12 indexed citations
12.
Vicario, Pasquale P., E.J. Brady, E E Slater, & R Saperstein. (1987). Insulin receptor tyrosine kinase activity is unaltered in ob/ob and db/db mouse skeletal muscle membranes. Life Sciences. 41(10). 1233–1241. 26 indexed citations
13.
Freidinger, Roger, S.F. Brady, William J. Paleveda, et al.. (1987). Synthesis of New Peptides Based on Models of Receptor-Bound Conformation. PubMed. 3. 12–19. 6 indexed citations
14.
NUTT, R. F., et al.. (1986). Somatostatin analogs with improved oral bioavailability.. PubMed. 64 Suppl 7. 71–3. 2 indexed citations
15.
Saperstein, R, et al.. (1978). Subcutaneous administration of somatostatin analogs as a major factor in the enhancement of the duration of action.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 235(1). 170–6. 2 indexed citations
16.
Veber, Daniel F., Frederick W. Holly, William J. Paleveda, et al.. (1978). Conformationally restricted bicyclic analogs of somatostatin.. Proceedings of the National Academy of Sciences. 75(6). 2636–2640. 112 indexed citations
17.
Saperstein, R, et al.. (1970). The involvement of RNA synthesis and cyclic AMP in the activation of fat cell lipolysis by growth hormone and glucocorticoids.. PubMed. 2. Suppl 2:20–7. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.V. Strout Breakdown of academic impact, for papers by David J. Cowan Breakdown of academic impact, for papers by A.V. Wallace Breakdown of academic impact, for papers by Philip J. Rybczynski Breakdown of academic impact, for papers by Edward J. Brady Breakdown of academic impact, for papers by Kazimir Sestanj Breakdown of academic impact, for papers by Janet Sredy Breakdown of academic impact, for papers by Kiyoshi Oizumi Breakdown of academic impact, for papers by Jaroslaw W. Żmijewski Breakdown of academic impact, for papers by Holger Heitsch
Rankless by CCL
2026